Introduction Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an advanced oncologic perfusion technique designed to treat peritoneal carcinomatosis, a condition where cancer spreads within the peritoneal cavity (Sugarbaker, 1995). This innovative approach..
Read More
Usage of HIPEC techniques for the first time in thoracic organs in advanced CA of pericardium. Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as well..
Read More
Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have demonstrated their impact on disease-free survival (DFS) and overall survival (OS) of patients with peritoneal metastases (PM). However, prior literature..
Read More
Abstract Importance Peritoneal metastasis in patients with locally advanced colon cancer (T4 stage) is estimated to recur at a rate of approximately 25% at 3 years from surgical resection and is..
Read More
Abstract Hyperthermic intraperitoneal chemotherapy (HIPEC), a new stage IV cancer treatment method conceived about 20 years ago, is a global game-changer in improving survival rates, however, not many patients in..
Read More
Abstract Purpose Emerging evidence suggests that hyperthermic intraperitoneal chemotherapy (HIPEC) with cytoreductive surgery (CRS) shows a survival benefit over CRS alone for patients with epithelial ovarian carcinoma (EOC). This systematic..
Read More